Stifel Nicolaus Sticks to Its Buy Rating for Mettler-Toledo (MTD)
In a report released today, Daniel Arias from Stifel Nicolaus maintained a Buy rating on Mettler-Toledo, with a price target of $1,450.00.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Arias covers the Healthcare sector, focusing on stocks such as 10x Genomics, Illumina, and Qiagen. According to TipRanks, Arias has an average return of -2.2% and a 45.39% success rate on recommended stocks.
In addition to Stifel Nicolaus, Mettler-Toledo also received a Buy from Barclays’s Luke Sergott in a report issued today. However, on October 24, TR | OpenAI – 4o reiterated a Hold rating on Mettler-Toledo (NYSE: MTD).
Based on Mettler-Toledo’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $983.22 million and a net profit of $202.35 million. In comparison, last year the company earned a revenue of $946.75 million and had a net profit of $221.81 million
Based on the recent corporate insider activity of 33 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MTD in relation to earlier this year. Most recently, in August 2025, Shawn Vadala, the CFO of MTD sold 300.00 shares for a total of $397,500.00.
Read More on MTD:
